| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |